General Information of the Compound
| Compound ID |
CP0153237
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine
1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-piperazine
1-(diphenylmethyl)-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine
1-Benzhydryl-4-cinnamylpiperazin
1-Cinnamyl-4-(diphenylmethyl)piperazine
1-benzhydryl-4-[(E)-3-phenylprop-2-enyl]piperazine
1-trans-Cinnamyl-4-diphenylmethylpiperazine
Aplactan
Aplexal
Apotomin
Artate
C 5270
Carecin
Cerebolan
Cero-Aterin
Cinaperazine
Cinarizina
Cinarizina [INN-Spanish]
Cinarizine
Cinazyn
Cinnacet
Cinnageron
Cinnarizine
Cinnarizine (JAN/USAN/INN)
Cinnarizine Stugeron
Cinnarizine [USAN:INN:BAN:JAN]
Cinnarizinum
Cinnarizinum [INN-Latin]
Corathiem
Denapol
Dimitron
Dimitronal
Eglen
Folcodal
Giganten
Glanil
Hilactan
Ixertol
Katoseran
Labyrin
Lazeta
Libotasin
MD 516
Marisan
Midronal
Mitronal
N-Benzhydryl-N'-cinnamylpiperazine
Olamin
Processine
R 1575
R 516
R-516
Sedatromin
Senoger
Sepan
Siptazin
Spaderizine
Stugeron
Stugeron (TN)
Stunarone (TN)
Stutgeron
Stutgin
Toliman
Votegol
Zepamol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H28N2
|
||||||||||||||||||
| Molecular Weight |
368.524
|
||||||||||||||||||
| Canonical SMILES |
C(\C=C\c1ccccc1)N1CCN(CC1)C(c1ccccc1)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+
Show/Hide
|
||||||||||||||||||
| InChIKey |
DERZBLKQOCDDDZ-JLHYYAGUSA-N
|
||||||||||||||||||
| CAS |
16699-20-0
298-57-7
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound